Published in J Virol on March 01, 2004
Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol (2010) 2.28
Inhibition of filovirus replication by the zinc finger antiviral protein. J Virol (2006) 1.76
Replicon system for Lassa virus. J Virol (2004) 1.69
Early and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeys. J Virol (2009) 1.45
Molecular diagnostics for lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from two years of laboratory operation. PLoS Negl Trop Dis (2012) 1.27
T cell-dependence of Lassa fever pathogenesis. PLoS Pathog (2010) 1.25
Interferon alfacon-1 protects hamsters from lethal pichinde virus infection. Antimicrob Agents Chemother (2005) 1.20
A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity. Vaccine (2007) 1.13
Inhibition of the type I interferon antiviral response during arenavirus infection. Viruses (2010) 1.11
Lassa virus nucleoprotein mutants generated by reverse genetics induce a robust type I interferon response in human dendritic cells and macrophages. J Virol (2011) 1.06
Junín virus infection activates the type I interferon pathway in a RIG-I-dependent manner. PLoS Negl Trop Dis (2012) 1.05
Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma. Virol J (2005) 1.04
Human dendritic cells infected with the nonpathogenic Mopeia virus induce stronger T-cell responses than those infected with Lassa virus. J Virol (2011) 1.02
In vitro and in vivo characterizations of pichinde viral nucleoprotein exoribonuclease functions. J Virol (2015) 0.96
Progress in the experimental therapy of severe arenaviral infections. Future Microbiol (2011) 0.90
Development of a new tacaribe arenavirus infection model and its use to explore antiviral activity of a novel aristeromycin analog. PLoS One (2010) 0.89
The exonuclease domain of Lassa virus nucleoprotein is involved in antigen-presenting-cell-mediated NK cell responses. J Virol (2014) 0.88
Immune responses and Lassa virus infection. Viruses (2012) 0.86
Pathogenic Old World arenaviruses inhibit TLR2/Mal-dependent proinflammatory cytokines in vitro. J Virol (2012) 0.86
Yellow fever virus infection in Syrian golden hamsters: relationship between cytokine expression and pathologic changes. Int J Clin Exp Pathol (2008) 0.85
The search for animal models for Lassa fever vaccine development. Expert Rev Vaccines (2013) 0.84
Simian TRIM5alpha proteins reduce replication of herpes simplex virus. Virology (2010) 0.84
Differential Inhibition of Macrophage Activation by Lymphocytic Choriomeningitis Virus and Pichinde Virus Is Mediated by the Z Protein N-Terminal Domain. J Virol (2015) 0.83
Molecular mechanism of arenavirus assembly and budding. Viruses (2012) 0.83
Arenavirus evasion of host anti-viral responses. Viruses (2012) 0.79
The synergistic effect of IFN-alpha and IFN-gamma against HSV-2 replication in Vero cells is not interfered by the plant antiviral 1-cinnamoyl-3, 11-dihydroxymeliacarpin. Virol J (2006) 0.78
Potent inhibition of Junín virus infection by interferon in murine cells. PLoS Negl Trop Dis (2014) 0.78
Genomic profiling of host responses to Lassa virus: therapeutic potential from primate to man. Future Virol (2015) 0.75
25-Hydroxycholesterol Inhibition of Lassa Virus Infection through Aberrant GP1 Glycosylation. MBio (2016) 0.75
Rapid and simple method for purification of nucleic acids. J Clin Microbiol (1990) 44.73
Antiviral actions of interferons. Clin Microbiol Rev (2001) 13.06
Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat Med (2002) 9.47
Lassa fever. Effective therapy with ribavirin. N Engl J Med (1986) 6.38
Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology (1995) 4.43
Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. J Virol Methods (1991) 3.78
A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis (1987) 3.51
Genetic diversity among Lassa virus strains. J Virol (2000) 3.00
PML protein isoforms and the RBCC/TRIM motif. Oncogene (2001) 2.99
Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J Cell Biol (1997) 2.98
Critical role for alpha/beta and gamma interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells. J Virol (2001) 2.69
Regulation of the interferon system: evidence that Vero cells have a genetic defect in interferon production. J Gen Virol (1979) 2.69
Imported lassa fever in Germany: molecular characterization of a new lassa virus strain. Emerg Infect Dis (2000) 2.69
Early diagnosis of Lassa fever by reverse transcription-PCR. J Clin Microbiol (1994) 2.65
Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects. J Virol (2003) 2.33
An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm. J Virol (1998) 2.20
MENINGITIS IN MAN CAUSED BY A FILTERABLE VIRUS : I. TWO CASES AND THE METHOD OF OBTAINING A VIRUS FROM THEIR SPINAL FLUIDS. J Exp Med (1936) 2.19
Pathologic and virologic study of fatal Lassa fever in man. Am J Pathol (1982) 2.14
Induction of the PML protein by interferons in normal and APL cells. Leukemia (1995) 2.05
Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor. J Gen Virol (1994) 1.89
Tumor necrosis factor alpha exerts powerful anti-influenza virus effects in lung epithelial cells. J Virol (2002) 1.82
Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. Proc Natl Acad Sci U S A (2002) 1.74
An IkappaB homolog encoded by African swine fever virus provides a novel mechanism for downregulation of proinflammatory cytokine responses in host macrophages. J Virol (1996) 1.73
Monitoring of clinical and laboratory data in two cases of imported Lassa fever. Microbes Infect (2002) 1.71
Overexpression of promyelocytic leukemia protein precludes the dispersal of ND10 structures and has no effect on accumulation of infectious herpes simplex virus 1 or its proteins. J Virol (2002) 1.67
Pathogenesis of viral hemorrhagic fevers: Rift Valley fever and Lassa fever contrasted. Rev Infect Dis (1989) 1.58
Resistance of lymphocytic choriomeningitis virus to alpha/beta interferon and to gamma interferon. J Virol (1994) 1.56
Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-kappaB. J Virol (2003) 1.55
Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML). Eur J Biochem (1996) 1.50
Noncytopathic clearance of lymphocytic choriomeningitis virus from the hepatocyte. J Exp Med (1999) 1.47
Lassa fever encephalopathy: Lassa virus in cerebrospinal fluid but not in serum. J Infect Dis (2001) 1.40
Two nuclear dot-associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis. Scand J Immunol (1995) 1.36
Rabies virus P and small P products interact directly with PML and reorganize PML nuclear bodies. Oncogene (2002) 1.33
Lassa virus hepatitis: a study of fatal Lassa fever in humans. Am J Trop Med Hyg (1986) 1.31
Temporal activation of NF-kappaB regulates an interferon-independent innate antiviral response against cytoplasmic RNA viruses. Proc Natl Acad Sci U S A (2003) 1.28
Human cytomegalovirus infection inhibits tumor necrosis factor alpha (TNF-alpha) signaling by targeting the 55-kilodalton TNF-alpha receptor. J Virol (2003) 1.28
Effects of promyelocytic leukemia protein on virus-host balance. J Virol (2002) 1.28
The interferon (IFN)-stimulated gene Sp100 promoter contains an IFN-gamma activation site and an imperfect IFN-stimulated response element which mediate type I IFN inducibility. J Biol Chem (1996) 1.17
Endemic Lassa fever in Liberia. III. Characterization of Lassa virus isolates. Trans R Soc Trop Med Hyg (1985) 1.17
Role of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virus. J Virol (2001) 1.14
Ocular avirulence of a herpes simplex virus type 1 strain is associated with heightened sensitivity to alpha/beta interferon. J Virol (1990) 1.12
Epitope mapping of the Lassa virus nucleoprotein using monoclonal anti-nucleocapsid antibodies. Arch Virol (1989) 1.12
Effects of tumor necrosis factor alpha on sin nombre virus infection in vitro. J Virol (2000) 1.12
Inhibition of tumor necrosis factor alpha-induced NF-kappa B activation by the adenovirus E3-10.4/14.5K complex. J Virol (2002) 1.10
Interferons, interferon inducers, and interferon-ribavirin in treatment of flavivirus-induced encephalitis in mice. Antimicrob Agents Chemother (2003) 1.09
3-deazaneplanocin A induces massively increased interferon-alpha production in Ebola virus-infected mice. Antiviral Res (2002) 0.99
Identification of interferon-resistant subpopulations in several strains of measles virus: positive selection by growth of the virus in brain tissue. J Virol (1990) 0.93
First outbreak of callitrichid hepatitis in Germany: genetic characterization of the causative lymphocytic choriomeningitis virus strains. Virology (2001) 0.91
Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med (2003) 27.97
Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science (2003) 18.34
Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med (2014) 16.45
Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis (2013) 7.83
Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J Clin Microbiol (2002) 6.60
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet (2003) 6.52
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature (2013) 6.39
Human betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and Europe. Emerg Infect Dis (2013) 5.25
Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol (2013) 4.98
A case of severe Ebola virus infection complicated by gram-negative septicemia. N Engl J Med (2014) 4.57
Bats host major mammalian paramyxoviruses. Nat Commun (2012) 4.15
Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines. MBio (2012) 3.96
Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013. Emerg Infect Dis (2014) 3.74
Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa. Emerg Infect Dis (2013) 3.61
Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013. Emerg Infect Dis (2014) 3.25
Detection and prevalence patterns of group I coronaviruses in bats, northern Germany. Emerg Infect Dis (2008) 3.00
Poor clinical sensitivity of rapid antigen test for influenza A pandemic (H1N1) 2009 virus. Emerg Infect Dis (2009) 2.86
Circulation of group 2 coronaviruses in a bat species common to urban areas in Western Europe. Vector Borne Zoonotic Dis (2010) 2.65
Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe. Transfusion (2002) 2.53
Distant relatives of severe acute respiratory syndrome coronavirus and close relatives of human coronavirus 229E in bats, Ghana. Emerg Infect Dis (2009) 2.52
Functional analysis of hepatitis B virus reactivating in hepatitis B surface antigen-negative individuals. Hepatology (2005) 2.49
Lymphotoxin-mediated crosstalk between B cells and splenic stroma promotes the initial type I interferon response to cytomegalovirus. Cell Host Microbe (2008) 2.40
Circulation of 3 lineages of a novel Saffold cardiovirus in humans. Emerg Infect Dis (2008) 2.35
Chikungunya fever in travelers returning to Europe from the Indian Ocean region, 2006. Emerg Infect Dis (2008) 2.29
Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol (2010) 2.28
Regulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications. Mol Cell Biol (2005) 2.28
Diagnostic reverse-transcription polymerase chain reaction kit for filoviruses based on the strain collections of all European biosafety level 4 laboratories. J Infect Dis (2007) 2.22
Novel human parvovirus 4 genotype 3 in infants, Ghana. Emerg Infect Dis (2010) 2.19
Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential. MBio (2013) 2.17
RT-PCR assay for detection of Lassa virus and related Old World arenaviruses targeting the L gene. Trans R Soc Trop Med Hyg (2007) 2.10
The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies. J Virol (2013) 2.10
Henipavirus RNA in African bats. PLoS One (2009) 2.10
High prevalence of common respiratory viruses and no evidence of Middle East respiratory syndrome coronavirus in Hajj pilgrims returning to Ghana, 2013. Trop Med Int Health (2015) 2.09
Response to imported case of Marburg hemorrhagic fever, the Netherland. Emerg Infect Dis (2009) 2.07
Investigation of anti-middle East respiratory syndrome antibodies in blood donors and slaughterhouse workers in Jeddah and Makkah, Saudi Arabia, fall 2012. J Infect Dis (2013) 2.06
Amplification of emerging viruses in a bat colony. Emerg Infect Dis (2011) 1.98
Mastomys natalensis and Lassa fever, West Africa. Emerg Infect Dis (2006) 1.94
Chikungunya fever in travelers: clinical presentation and course. Clin Infect Dis (2007) 1.93
Imported Lassa fever in Germany: surveillance and management of contact persons. Clin Infect Dis (2003) 1.91
Antibodies against MERS coronavirus in dromedary camels, Kenya, 1992-2013. Emerg Infect Dis (2014) 1.89
Generic detection of coronaviruses and differentiation at the prototype strain level by reverse transcription-PCR and nonfluorescent low-density microarray. J Clin Microbiol (2007) 1.89
Outbreaks of disease suspected of being due to human monkeypox virus infection in the Democratic Republic of Congo in 2001. J Clin Microbiol (2002) 1.86
Molecular diagnostics of viral hemorrhagic fevers. Antiviral Res (2003) 1.82
Prevalence, types, and RNA concentrations of human parechoviruses, including a sixth parechovirus type, in stool samples from patients with acute enteritis. J Clin Microbiol (2007) 1.79
Inhibition of filovirus replication by the zinc finger antiviral protein. J Virol (2006) 1.76
Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection. J Exp Med (2008) 1.76
Spectrum of viruses and atypical bacteria in intercontinental air travelers with symptoms of acute respiratory infection. J Infect Dis (2007) 1.75
Real-time PCR system for detection of orthopoxviruses and simultaneous identification of smallpox virus. J Clin Microbiol (2004) 1.74
Monitoring of clinical and laboratory data in two cases of imported Lassa fever. Microbes Infect (2002) 1.71
MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997. Emerg Infect Dis (2014) 1.71
Replicon system for Lassa virus. J Virol (2004) 1.69
Bats worldwide carry hepatitis E virus-related viruses that form a putative novel genus within the family Hepeviridae. J Virol (2012) 1.69
Crimean-Congo hemorrhagic fever in Kosovo. J Clin Microbiol (2002) 1.64
Diagnosing schistosomiasis by detection of cell-free parasite DNA in human plasma. PLoS Negl Trop Dis (2009) 1.63
Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clin Infect Dis (2006) 1.62
Hantavirus in bat, Sierra Leone. Emerg Infect Dis (2012) 1.60
Laboratory diagnosis of primary and secondary dengue infection. J Clin Virol (2004) 1.57
The N-terminal domain of the arenavirus L protein is an RNA endonuclease essential in mRNA transcription. PLoS Pathog (2010) 1.57
Epizootic emergence of Usutu virus in wild and captive birds in Germany. PLoS One (2012) 1.55
Isolation and phylogenetic analysis of Sindbis viruses from mosquitoes in Germany. J Clin Microbiol (2010) 1.55
Isolation of usutu virus in Germany. Am J Trop Med Hyg (2011) 1.55
Evidence for novel hepaciviruses in rodents. PLoS Pathog (2013) 1.54
Coronavirus antibodies in African bat species. Emerg Infect Dis (2007) 1.54
Virus detection and monitoring of viral load in Crimean-Congo hemorrhagic fever virus patients. Emerg Infect Dis (2007) 1.53
A novel diagnostic target in the hepatitis C virus genome. PLoS Med (2009) 1.52
Sequence analysis of L RNA of Lassa virus. Virology (2004) 1.50
NAT screening of blood donors for severe acute respiratory syndrome coronavirus can potentially prevent transfusion associated transmissions. Transfusion (2004) 1.49
Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP-10 gradient. J Clin Invest (2004) 1.49
Functional analysis of complex hepatitis B virus variants associated with development of liver cirrhosis. Gastroenterology (2006) 1.46
Improved detection of Lassa virus by reverse transcription-PCR targeting the 5' region of S RNA. J Clin Microbiol (2010) 1.45
Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol (2011) 1.44
Replicative Capacity of MERS Coronavirus in Livestock Cell Lines. Emerg Infect Dis (2014) 1.42
Evidence for a decrease in transmission of Ebola virus--Lofa County, Liberia, June 8-November 1, 2014. MMWR Morb Mortal Wkly Rep (2014) 1.42
The N-linked glycan g15 within the V3 loop of the HIV-1 external glycoprotein gp120 affects coreceptor usage, cellular tropism, and neutralization. Virology (2002) 1.41
Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist. J Virol (2013) 1.40
Xenotropic murine leukemia virus-related gammaretrovirus in respiratory tract. Emerg Infect Dis (2010) 1.40
Evaluation of advanced reverse transcription-PCR assays and an alternative PCR target region for detection of severe acute respiratory syndrome-associated coronavirus. J Clin Microbiol (2004) 1.40
Rates of and reasons for failure of commercial human immunodeficiency virus type 1 viral load assays in Brazil. J Clin Microbiol (2007) 1.37
Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease. J Virol (2011) 1.37
Novel human parechovirus from Brazil. Emerg Infect Dis (2009) 1.36
MassTag polymerase chain reaction for differential diagnosis of viral hemorrhagic fever. Emerg Infect Dis (2006) 1.35
Analysis of two imported cases of yellow fever infection from Ivory Coast and The Gambia to Germany and Belgium. J Clin Virol (2005) 1.33